Advocacy - Tax and Fiscal

CLSA Comments to SEC in Support of Proposed Rule on Small Company Exemptions from SOX 404(b)- June 2019

June 10, 2019

Ms. Vanessa A. Countryman
Acting Secretary
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549

Re: Amendments to the Accelerated Filer and Large Accelerated Filer Definitions; Proposed Rules; Request for Comments [File Number S7-06-19]

Dear Ms. Countryman:

The California Life Sciences Association (CLSA) appreciates the opportunity to submit written comments in response to the Securities and Exchange Commission’s (SEC or “the Commission”)
proposed rules on Amendments to the Accelerated Filer and Large Accelerated Filer Definitions. [File Number S7-06-19]

CLSA is the statewide public policy organization representing California’s life sciences innovators, including medical device, diagnostic, biotechnology and pharmaceutical companies,
research universities and private, non-profit institutes, and venture capital firms. CLSA’s diverse membership represents the spectrum of organizations throughout California working to develop life-saving and life-sustaining therapies and treatments in the life sciences innovation ecosystem.